Frontline Treatment Approaches to Nonmetastatic CRPC - Targeted Oncology
7/4/2022 12:00:00 AM2 years 9 months ago
by Alan Bryce, MD, Eleni Efstathiou, MD, Daniel Landau, MD
by Alan Bryce, MD, Eleni Efstathiou, MD, Daniel Landau, MD
Returning to the patient case, experts review available frontline treatment options in the setting of nonmetastatic castration-resistant prostate cancer.
Transcript: Eleni Efstathiou, MD, PhD: This is hindsight. We know from the beginning that this is a high-risk disease and that a single modality such as only the prostatectomy will not suffice. Do I… [+3465 chars]
full article...